Fact Sheet: MASH Clinical Development
MASH CRO Expertise for Complex Clinical Trials
As MASH clinical development continues to evolve, sponsors face increasing challenges in patient identification, complex eligibility criteria, high screening failure rates, and competition for experienced investigators and sites. Success demands scientific expertise, specialized networks, and innovative approaches to recruitment and trial delivery.
P95 Julius Clinical combines deep MASH expertise, full-service CRO capabilities, and leadership within GRIPonMASH, a pan-European initiative advancing MASH detection and diagnosis. Supported by a global MASH investigator network and dedicated scientific oversight, we help sponsors improve feasibility, optimize recruitment strategies, and successfully execute complex MASH clinical trials.
Download our MASH Fact Sheet to learn how P95 Julius Clinical supports sponsors through every stage of development, leveraging scientific leadership, specialized site networks, patient identification strategies, and operational excellence to accelerate study delivery.
Complete the form to access the fact sheet.
Related resources
Poster Presentation: GRIPonMASH Preliminary Results
Comparing FIB-4 and MAF-5 for Advanced Fibrosis Screening in Primary Care Complete the form to access the poster and explore the preliminary GRIPonMASH findings.[gravityform id="19" title="false"]As the prevalence of MASLD and MASH contin...